Engineering of microscale vascularized fat that responds to perfusion with lipoactive hormones.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30284537.
- Also identified by DOI 10.1088/1758-5090/aae5fe and PMC identifier 6252090.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Current methods to treat large soft-tissue defects mainly rely on autologous transfer of adipocutaneous flaps, a method that is often limited by donor site availability. Engineered vascularized adipose tissues can potentially be a viable and readily accessible substitute to autologous flaps. In this study, we engineered a small-scale adipose tissue with pre-patterned vasculature that enables immediate perfusion. Vessels formed after one day of perfusion and displayed barrier function after three days of perfusion. Under constant perfusion, adipose tissues remained viable and responded to lipoactive hormones insulin and epinephrine with lipid accumulation and loss, respectively. Adipocyte growth correlated inversely with distance away from the feeding vessel, as predicted by a Krogh-type model.
Medical subject headings
- Adipose Tissue
- Epinephrine
- Insulin
- Microvessels
- Tissue Engineering